Mucormycoses: serious complication of high-dose corticosteroid therapy for traumatic optic neuropathy

International Journal of Oral and Maxillofacial Surgery

Volumn 37, Issue 4, 2008, Pages 391-394

  Dojcinovic, I ^a   Richter, M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMBISOMEW; AMOXICILLIN; AMPHOTERICIN B; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; METHYLPREDNISOLONE; POSACONAZOLE; UNCLASSIFIED DRUG;

ABSCESS; ABSCESS DRAINAGE; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MANDIBLE FRACTURE; MAXILLA OSTEOTOMY; MAXILLOFACIAL INJURY; MUCORMYCOSIS; OPTIC NERVE DISEASE; OSTEOSYNTHESIS; PHYSICAL EXAMINATION; VISUAL ACUITY; VITAL SIGN; WOUND INFECTION;

ABSCESS; ANTIFUNGAL AGENTS; GLUCOCORTICOIDS; HUMANS; JAW FRACTURES; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MUCORMYCOSIS; OPTIC NERVE DISEASES; RETROBULBAR HEMORRHAGE; STREPTOCOCCAL INFECTIONS; TRIAZOLES;

EID: 41249097917     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2007.09.177     Document Type: Article

References (15)

1. Anderson R.L., Panje W.R., and Gross C.E. Optic nerve blindness following blunt forehead trauma. Ophthalmology 89 (1982) 445-455
2. Cook M.W., Levin L.A., Joseph M.P., and Pinczower E.F. Traumatic optic neuropathy. A meta-analysis. Arch Otolaryngol Head Neck Surg 122 (1996) 389-392
3. Dannaoui E., Meis J.F., Loebenberg D., and Verweij P.E. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 47 (2003) 3647-3650
4. Eng R.H., Person A., Mangura C., Chmel H., and Corrado M. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole. Antimicrob Agents Chemother 20 (1981) 688-690
5. Eucker J., Sezer O., Graf B., and Possinger K. Mucormycoses. Mycoses 44 (2001) 253-260
6. Girotto J.A., Gamble W.B., Robertson B., Redett R., Muehlberger T., Mayer M., Zinreich J., Iliff N., Miller N., and Manson P.N. Blindness after reduction of facial fractures. Plast Reconstr Surg 102 (1998) 1821-1834
7. Greenberg R.N., Scott L.J., Vaughn H.H., and Ribes J.A. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 17 (2004) 517-525
8. Levin L.A., Beck R.W., Joseph M.P., Seiff S., and Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology 106 (1999) 1268-1277
9. Lopez-Berestein G., Fainstein V., Hopfer R., Mehta K., Sullivan M.P., Keating M., Rosenblum M.G., Mehta R., Luna M., and Hersh E.M. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis 151 (1985) 704-710
10. Lubben B., Stoll W., and Grenzebach U. Optic nerve decompression in the comatose and conscious patients after trauma. Laryngoscope 111 (2001) 320-328
11. Paltauf A.P. Mycosis mucorina. Virchows Arch 102 (1885) 543-564
12. Prabhu R.M., and Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 10 (2004) 31-47
13. Ribes J.A., Vanover-Sams C.L., and Baker D.J. Zygomycetes in human disease. Clin Microbiol Rev 13 (2000) 236-301
14. Scalise A., Barchiesi F., Viviani M.A., Arzeni D., Bertani A., and Scalise G. Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot. J Infect 38 (1999) 191-192
15. Yohai R.A., Bullock J.D., Aziz A.A., and Markert R.J. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 39 (1994) 3-22